TNFSF10 and Schwartz-Jampel syndrome: Both scRNA-seq and bulk RNA-seq transcriptomic analyses identified increased expression of TNFSF10 (TRAIL) in monocytes among SjS patients, suggesting TNFSF10 high/+ monocytes as a potential key player in SjS pathogenesis and a promising target for SjS treatment.